CF PharmTech, Inc. (HKG:2652)
Hong Kong
· Delayed Price · Currency is HKD 28.98
-0.52 (-1.76%)
Last updated: Mar 10, 2026, 1:31 PM HKT
CF PharmTech Revenue
CF PharmTech had revenue of 135.94M CNY in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 603.93M. In the year 2024, CF PharmTech had annual revenue of 607.75M with 9.23% growth.
Revenue (ttm)
603.93M CNY
Revenue Growth
+9.23%
P/S Ratio
18.75
Revenue / Employee
1.05M CNY
Employees
574
Market Cap
12.14B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 607.75M | 51.33M | 9.23% |
| Dec 31, 2023 | 556.42M | 207.29M | 59.37% |
| Dec 31, 2022 | 349.13M | 307.14M | 731.54% |
| Dec 31, 2021 | 41.99M | 37.13M | 764.11% |
| Dec 31, 2020 | 4.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| CanSino Biologics | 1.19B |
| Consun Pharmaceutical Group | 3.58B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Luye Pharma Group | 6.76B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| SSY Group | 4.58B |